Restore your vitality with NAD+

Restore your vitality with NAD+

FSA / HSA Eligible

$149 / Month

Any Dose

  • Transparent pricing with no hidden fees

  • No insurance needed

  • Transparent pricing

  • FSA/HSA Eligible

Cellular Rejuvenation: The Next Frontier in Health

Revitalize your body from the inside out with Nucore’s injectable NAD⁺. Unlike oral supplements that are often broken down during digestion, our pharmaceutical-grade Nicotinamide Adenine Dinucleotide (NAD⁺) is delivered into your bloodstream through a subcutaneous injection or nasal spray, ensuring maximum absorption and faster, more noticeable results. This powerful coenzyme is the cornerstone of cellular health, driving energy production, DNA repair, and the function of key longevity proteins known as sirtuins.

As natural NAD⁺ levels decline with age, so does our cellular vitality, leading to fatigue, reduced mental clarity, and a slower metabolism. Nucores’ injectable NAD⁺ therapy offers a powerful and efficient way to replenish these essential levels, helping to support improved energy, mental focus, and overall physical performance. Take control of your health and unlock your body’s potential with Nucores NAD⁺.

Frequently Asked Questions

Nicotinamide adenine dinucleotide (NAD⁺) is a coenzyme found in all living cells. It’s crucial for fundamental biological processes, acting as a key player in cellular metabolism, helping convert nutrients into energy (ATP). NAD⁺ also serves as a substrate for important enzymes involved in DNA repair, gene expression, and cellular stress responses. [1-5]

Maintaining adequate levels of NAD⁺ is essential for cellular health and function. A decline in NAD⁺ levels is a natural part of aging and is also observed in various disease states. This reduction can lead to mitochondrial dysfunction, impaired metabolic processes, and increased oxidative stress. The age-related decline in NAD⁺ is believed to contribute to many degenerative conditions. [1, 6]

NAD⁺ levels can be restored through supplementation with precursors like nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). These molecules are efficiently converted by the body into NAD⁺, bypassing some of the metabolic pathways that slow down with age. Injectable forms of NAD⁺ can also be used to ensure maximum absorption and bioavailability. [7]

Restoring or increasing NAD⁺ levels through supplementation shows promise in improving metabolic health, cardiovascular function, and neuroprotection. In preclinical and early clinical studies, increasing NAD⁺ has been linked to potential improvements in muscle insulin sensitivity, a reduction in inflammatory markers, and enhanced quality of life in conditions like chronic fatigue and Parkinson’s disease. However, more research is needed to fully understand its long-term effects and optimal use. [1, 7]

While many studies indicate a favorable safety profile with a low incidence of mild side effects, the long-term safety, clinical efficacy, and optimal dosing of NAD⁺ augmentation strategies still require further investigation in large-scale human trials. [6]

References

Braidy, N., Berg, J., Clement, J., Khorshidi, F., Poljak, A., Jayasena, T., Grant, R., & Sachdev, P. (2019). Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes. Antioxidants & redox signaling, 30(2), 251–294.

https://doi.org/10.1089/ars.2017.7269

Arenas-Jal, M., Suñé-Negre, J. M., & García-Montoya, E. (2020). Therapeutic potential of nicotinamide adenine dinucleotide (NAD). European journal of pharmacology, 879, 173158.

https://doi.org/10.1016/j.ejphar.2020.173158

Griffiths, H. B. S., Williams, C., King, S. J., & Allison, S. J. (2020). Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target. Biochemical Society transactions, 48(3), 733–744.

https://doi.org/10.1042/BST20190033

Tannous, C., Booz, G. W., Altara, R., Muhieddine, D. H., Mericskay, M., Refaat, M. M., & Zouein, F. A. (2021). Nicotinamide adenine dinucleotide: Biosynthesis, consumption and therapeutic role in cardiac diseases. Acta physiologica (Oxford, England), 231(3), e13551.

https://doi.org/10.1111/apha.13551

 Yaku, K., Okabe, K., Gulshan, M., Takatsu, K., Okamoto, H., & Nakagawa, T. (2019). Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD). Scientific reports, 9(1), 13102. https://doi.org/10.1038/s41598-019-49547-6

Yaku, K., & Nakagawa, T. (2023). NAD+ Precursors in Human Health and Disease: Current Status and Future Prospects. Antioxidants & redox signaling, 39(16-18), 1133–1149.

https://doi.org/10.1089/ars.2023.0354

Important Disclaimer

These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease.

Experience The Future Of Metabolic Optimization With Nucore.